# Regeneron Pharmaceuticals, Inc. (REGN) — Q1-2010 Earnings Results

**Report date:** 2010-04-29 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/REGN/earnings/Q1-2010

## Post-Earnings Brief

### Headline

Regeneron Pharmaceuticals Beats on EPS, Stock Up 9.67%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.38 | N/A | +22.61% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding their financial performance. They focused on the importance of continued innovation and development.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite not providing revenue figures.

> They highlighted ongoing research and development efforts as a priority.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Regeneron's earnings report showed a surprise in EPS, which likely contributed to the stock's strong one-day performance, rising by 9.67%. The lack of revenue figures might raise questions among investors, but the positive EPS surprise suggests the company is managing costs effectively. Management's focus on R&D indicates a commitment to future growth, which may reassure investors.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/REGN/earnings/Q1-2010_